Literature DB >> 749494

I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects.

R Prando, R Cordera, A De Micheli, M Maiello, P Odetti, G Viviani, L Corsi, L Adezati.   

Abstract

Insulin response and FFA behavior have been evaluated during an IVGTT in 63 subjects of whom 18 were normal, 31 were obese (with varying degrees of carbohydrate tolerance) and 14 were mild non insulin-dependent diabetics. The extreme reduction of insulin secretion in the early phase (delta 0-15 min) and the less severe impairment of the late phase (delta 15-60 min) have been confirmed; obese subjects showed on the average an active insulin response to venous loading; this was more marked and more consistent in the late phase. Compared to controls, FFA concentration both in basal conditions and during IVGTT was progressively higher in obese and diabetic patients. When analyzing the interplay between IRI, KG and FFA in the course of IVGTT, it was observed that: (1) a close correlation exists between IG and early insulin response (r = 0.72); (2) a correlation between delta IRI 0-15 min and percentage decrease of FFA at 45 min is found only in normal subjects; (3) a negative highly significant correlation is found between KG and mean FFA plasma level 0-60 min. This last correlation is evidence of the important role played by FFA in carbohydrate tolerance. The conflicting results reported by others have been discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 749494     DOI: 10.1007/bf02590749

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  71 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study.

Authors:  E Cerasi; R Luft; S Efendic
Journal:  Diabetes       Date:  1972-04       Impact factor: 9.461

3.  Early insulin response to glucose stimulation in siblings of juvenile diabetics.

Authors:  G Sterky; J I Thorell
Journal:  Acta Endocrinol (Copenh)       Date:  1973-08

4.  Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids.

Authors:  A S Luyckx; P J Lefebvre
Journal:  Proc Soc Exp Biol Med       Date:  1970-02

5.  Normal initial plasma insulin response in mild diabetes.

Authors:  K Johansen
Journal:  Metabolism       Date:  1972-12       Impact factor: 8.694

6.  Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid.

Authors:  T A Miettinen; M R Taskinen; R Pelkonen; E A Nikkilä
Journal:  Acta Med Scand       Date:  1969-10

7.  Plasma amino acid levels and insulin secretion in obesity.

Authors:  P Felig; E Marliss; G F Cahill
Journal:  N Engl J Med       Date:  1969-10-09       Impact factor: 91.245

8.  Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade.

Authors:  J E Vance; K D Buchanan; D O'Hara; R H Williams; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958

9.  Department of Medicina, Faculdade de Medicina da Universidade de São Paulo, Brazil.

Authors:  A A Pupo; M J Ursich; E Iamaguchi; F G Vasconcellos
Journal:  Diabetes       Date:  1976-03       Impact factor: 9.461

10.  Interrelationship of free fatty acids and glucose metabolism in the dog.

Authors:  P Paul; B Issekutz; H I Miller
Journal:  Am J Physiol       Date:  1966-12
View more
  2 in total

1.  Adipose and Liver Function in Primate Offspring with Insulin Resistance Induced by Estrogen Deprivation in Utero.

Authors:  Soon Ok Kim; Graham Aberdeen; Terrie J Lynch; Eugene D Albrecht; Gerald J Pepe
Journal:  Endocrinol Diabetes Metab J       Date:  2017-09-12

2.  Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.

Authors:  M Clark; K Thomaseth; L Dirikolu; D C Ferguson; M Hoenig
Journal:  J Vet Intern Med       Date:  2014 Jan-Feb       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.